Inventor

FISCHETTI VINCENT A

US48 patents

⚠️ This page may combine multiple inventors who share the name “FISCHETTI VINCENT A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FISCHETTI VINCENT A

UNIV ROCKEFELLER

Polypeptide of a hybrid surface protein by bacteria

Process for isolating cellular components

Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria

Production of streptococcal m protein immunogens and molecular probes

Recombinant poxvirus and streptococcal M protein vaccine

Method for screening inhibitors of the enzyme which cleaves the anchor of surface proteins from gram positive bacteria

Lytic enzymes and spore surface antigen for detection and treatment of Bacillus anthracis bacteria and spores

Phage-associated lytic enzymes for treatment of Bacillus anthracis and related conditions

C1 bacteriophage lytic system

Delivery and expression of a hybrid surface protein by bacteria

Regulation of exoprotein in Staphylococcus aureus

Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria

Immunoglobulin a binding protein

Immunoglobulin a binding protein

Streptococcal immunoglobulin a binding protein encoded by emmL2.2

Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions

Fibronectin and fibrinogen binding protein from group A streptococci

Receptor for Mycobacterium leprae and methods of use thereof

Bacterial plasmin binding protein and methods of use thereof

DNA encoding fibronectin and fibrinogen binding protein from group A streptococci

Gene serum opacity factor

Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria

Chimeric bacteriophage lysin with activity against staphylococci bacteria

Synthetic peptides from streptococcal M protein and vaccines prepared therefrom

Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria

Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria

Chimeric bacteriophage lysin with activity against Staphylococci bacteria

Chimeric bacteriophage lysin with activity against staphylococci bacteria

Dimeric bacteriophage lysins

Glycosylated LPXTGases and uses thereof

Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria

Dimeric bacteriophage lysins

FISCHETTI VINCENT A

Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria

Dimeric bacteriophage lysins

Ply-GBS mutant lysins

Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria

Phage-associated lytic enzymes for treatment of Bacillus anthracis and related conditions

Chimeric bacteriophage lysin with activity against Staphylococci bacteria

NEW HORIZONS DIAGNOSTICS CORP

Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses

Method for exposing Group A streptococcal antigens and an improved diagnostic test for the identification of Group A streptococci

SIGA PHARMACEUTICALS INC

Use of gram-positive bacteria to express recombinant proteins

Regulation of exoprotein in staphylococcus aureus

NOWINSKI ROBERT C

Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria

Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria

(unassigned)

Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections

UNIV CORNELL

Methods to protect against and treat multiple sclerosis

YOONG PAULINE

Bacteriophage lysins for Bacillus anthracis

BEARSS DAVID J

Oxo-imidazolyl compounds